BEIJING: An experimental coronavirus vaccine developed by China’s Clover Biopharmaceuticals appeared to be safe and able to trigger immune responses in animal tests, researchers have said. The result of the study on monkeys comes months after Clover began an early stage human trial in Australia in June, as global drug makers race to develop a safe and effective vaccine that …
Read More »Clover says its COVID-19 vaccine candidate showed promise
September 25, 2020